PEDRO PIEDRA to Drug Evaluation, Preclinical
This is a "connection" page, showing publications PEDRO PIEDRA has written about Drug Evaluation, Preclinical.
Connection Strength
0.171
-
Establishing Correlates of Protection for Vaccine Development: Considerations for the Respiratory Syncytial Virus Vaccine Field. Viral Immunol. 2018 03; 31(2):195-203.
Score: 0.140
-
GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process. Antimicrob Agents Chemother. 2015 Dec 14; 60(3):1264-73.
Score: 0.030